http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111317736-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 |
| filingDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111317736-B |
| titleOfInvention | Application of quinoline alkaloid in preparation of medicine for treating atherosclerosis |
| abstract | The invention discloses an application of quinoline alkaloid in preparing a medicament for treating atherosclerosis, and belongs to the technical field of medical application of quinoline alkaloid. The research of the invention finds that the scandine can play a role in stabilizing atherosclerotic plaques by inhibiting the angiogenesis in the plaques and the level of chemotactic factor CX3CL1, so the scandine can be used as an effective tool for molecular mechanism research of atherosclerosis or preparing drugs for treating atherosclerosis, and the invention lays a foundation for developing new drugs for treating atherosclerosis. |
| priorityDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.